Skip to main content
Total HealthSupply
Famotidine Tablets, USP, 20 mg, 100 Count Bottle
Available to order

Famotidine Tablets, USP, 20 mg, 100 Count Bottle

SKU ASL 67877084201

$4.65

Selling unit is not specified. Confirm the selling unit with customer care before ordering if unclear.

Purchase options

Request quote
Brand
Ascend Laboratories LLC

Categories

Product details

Product Specifications

Specification Details
Manufacturer / Brand Ascend Laboratories, LLC
Manufacturer # / SKU 67877084201
NDC Number 67877-0842-01
Active Ingredient Famotidine 20 mg
Application Gastric Acid Reducer
Dosage Form Tablet (Film-Coated)
Strength 20 mg
Color / Shape Beige / Round
Markings "A" on one side; "1" on the other
Packaging / Sold As Bottle of 100 Tablets
Storage Requirements USP Controlled Room Temperature 20°C to 25°C
UNSPSC Code 51102710

Key Features

  • Potent Acid Suppression: Significantly reduces basal and nocturnal gastric acid secretion, as well as secretion stimulated by food and pentagastrin.

  • Rapid Symptom Relief: Onset of action typically occurs within one hour of oral administration, with effects lasting up to 10 to 12 hours.

  • Small, Easy-to-Swallow Tablets: The film-coated round tablets are designed for patient comfort and compliance.

  • Low Drug Interaction Profile: Unlike some other H2 blockers (like cimetidine), famotidine does not interfere with the cytochrome P450 enzyme system, making it safer for patients on multiple medications.

  • Clinical Standard: A primary choice for treating active ulcers and preventing their recurrence.

Clinical Applications

  • Duodenal Ulcers: Short-term treatment of active duodenal ulcers and maintenance therapy at reduced dosage after healing.

  • Gastric Ulcers: Short-term treatment (up to 8 weeks) of benign active gastric ulcers.

  • Gastroesophageal Reflux Disease (GERD): Short-term treatment of patients with symptoms of GERD and for the treatment of erosive esophagitis.

  • Pathological Hypersecretory Conditions: Management of conditions such as Zollinger-Ellison Syndrome.

⚠️ Usage Note: For patients with moderate or severe renal insufficiency, the dose may need to be adjusted by a physician to prevent accumulation of the drug.

⚠️ Safety: While generally well-tolerated, rare side effects may include headache, dizziness, constipation, or diarrhea.

⚠️ Interaction Warning: Use of H2 blockers may reduce the absorption of certain drugs that require an acidic stomach environment, such as ketoconazole or iron salts.